Literature DB >> 7283296

Acute pulmonary disease caused by phenytoin.

J R Michael, M L Rudin.   

Abstract

Acute pulmonary disease may occur as part of the hypersensitivity angitis produced by phenytoin sodium. The clinical features of the pulmonary involvement are fever, dyspnea, hypoxemia, and bilateral radiographic infiltrates. The pathologic process is an interstitial pneumonitis that appears reversible with cessation of the drug and treatment with corticosteroids.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7283296     DOI： 10.7326/0003-4819-95-4-452

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  6 in total

Review 1.  Anticonvulsant hypersensitivity syndrome in children: incidence, prevention and management.

Authors:  Alberto Verrotti; Daniela Trotta; Carmela Salladini; Francesco Chiarelli
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

Authors:  N H Shear; S P Spielberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  Diphenylhydantoin (phenytoin)-induced chronic pulmonary disease.

Authors:  Ramakant Dixit; Kalpana Dixit; Paras Nuwal; Arunima Banerjee; Sidharth Sharma; Lokendra Dave
Journal:  Lung India       Date:  2009-10

4.  Acute respiratory failure caused by phenytoin overdose.

Authors:  Chang Kyung Kang; Min-Kyung Kim; Min Jae Kim; Kang Il Jun; Ki Woong Kim; Seong-Ho Park; Kyoung-Ho Song
Journal:  Korean J Intern Med       Date:  2013-10-29       Impact factor: 2.884

5.  Phenytoin-induced isolated chronic, nocturnal dry cough.

Authors:  Fábio A Nascimento; Bruno Toshio Takeshita; Pedro A Kowacs
Journal:  Epilepsy Behav Case Rep       Date:  2016-03-16

6.  Phenytoin-induced acute hypersensitivity pneumonitis.

Authors:  Pallavi Periwal; Sharad Joshi; Rajesh Gothi; Deepak Talwar
Journal:  Lung India       Date:  2015 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.